Medesis Pharma S.A.
ALMDP | PA
Overview
Corporate Details
- ISIN(s):
- FR0010844464
- LEI:
- 969500C15M96P00UR648
- Country:
- France
- Address:
- AVENUE DU GOLF, 34670 BAILLARGUES
- Website:
- https://www.medesispharma.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Medesis Pharma is a clinical-stage Pharmaceutical Biotechnology company developing innovative technology (AONYS®) for the delivery of therapeutic molecules to treat diseases with no current efficacious treatment. Legal structure : Montpellier (France) Headquarters Montreal (Canada) 100% subsidiary. Medesis Pharma Inc. is a subsidiary for collaborations with McGill University and the University of Montreal.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-20 12:00 |
Legal Proceedings Report
MEDESIS PHARMA : OUVERTURE D'UNE PROCÉDURE DE LIQUIDATION JUDICIAIRE
|
French | 184.2 KB | |
| 2024-11-20 17:45 |
Earnings Release
MEDESIS PHARMA A FINALISÉ L’ÉTUDE CLINIQUE POUR LE TRAITEMENT DE LA MALADIE D’A…
|
French | 685.0 KB | |
| 2024-11-20 17:45 |
Inside Information Statement
MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'…
|
English | 614.2 KB | |
| 2024-11-14 18:00 |
Regulatory News Service
MEDESIS PHARMA : CONVERSION DE LA PROCÉDURE DE SAUVEGARDE EN REDRESSEMENT JUDIC…
|
French | 314.0 KB | |
| 2024-11-12 18:00 |
Interim Report
MEDESIS PHARMA : Rapport Financier Semestriel 2024
|
French | 2.5 MB | |
| 2024-11-12 18:00 |
Inside Information Statement
MEDESIS PHARMA : Activités & résultats du 1er semestre 2024
|
French | 1.1 MB | |
| 2024-10-08 08:00 |
Regulatory News Service
Participation de MEDESIS PHARMA au Congrès mondial pour les études cliniques s…
|
French | 487.6 KB | |
| 2024-10-08 08:00 |
Regulatory News Service
MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alz…
|
English | 461.5 KB | |
| 2024-09-20 08:00 |
Inside Information Statement
MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai cliniq…
|
French | 236.8 KB | |
| 2024-09-04 17:45 |
General Meeting Notice
MEDESIS PHARMA : MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES À L’ASSEMBLÉE G…
|
French | 274.7 KB | |
| 2024-07-15 08:00 |
Inside Information Statement
MEDESIS PHARMA : ACTIVITÉS & RÉSULTATS ANNUELS 2023
|
French | 828.9 KB | |
| 2024-07-15 08:00 |
Annual Report
MEDESIS PHARMA: 2023 FULL-YEAR BUSINESS AND EARNINGS
|
English | 737.2 KB | |
| 2024-06-03 18:00 |
Capital/Financing Update
MEDESIS PHARMA : Obtention d’un financement pour poursuivre l'analyse des résul…
|
French | 498.8 KB | |
| 2024-03-19 18:01 |
Inside Information Statement
Termination of the agreement between NICE and GREEN S.A. and Medesis Pharma
|
English | 264.7 KB | |
| 2024-03-19 18:01 |
Inside Information Statement
Medesis Pharma : Résiliation du contrat avec la société NICE & GREEN S.A.
|
French | 302.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-16 | N/A | Other | Sell | 1,000 | 1,170.00 EUR |
| 2024-01-18 | N/A | Other | Sell | 800 | 669.60 EUR |
| 2023-07-21 | N/A | Other | Sell | 1,000 | 1,400.00 EUR |
| 2023-07-04 | N/A | Other | Sell | 5,000 | 7,100.00 EUR |
| 2023-05-23 | N/A | Other | Sell | 3,140 | 6,908.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |